EndoGastric Solutions Receives $21,500,000 Series E Round

  • Feed Type
  • Date
  • Company Name
    EndoGastric Solutions
  • Mailing Address
    8210 154th Ave NE Redmond, WA 98052
  • Company Description
    EndoGastric Solutions, Inc. (FKA Esophyx) is the pioneer in endoluminal procedures for the treatment of upper gastrointestinal diseases, including gastroesophageal reflux disease (GERD) and obesity. EGS’ mission is to utilize the most current wisdom in gastroenterology and surgery to develop new trans-oral procedures and products to address the largest unmet needs in gastrointestinal diseases.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
    Series E
  • Proceeds Purposes
    The funding will be used to support an expanding commercial presence for the company’s market-leading Natural Orifice Surgery (NOS) platform, which includes the EsophyX and StomaphyX surgical devices.
  • M&A Terms
  • Venture Investor
    Advanced Technology Ventures

Trending on Xconomy